Cargando…

Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM)

Herpes zoster (HZ) is the infectious reactivation of the varicella-zoster virus. HZ is more frequent in immunocompromised subjects, including patients with cancer. HZ complications can even last for years with a consequent delay in treatment of the underlying malignancy and with an unfavorable impac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pedrazzoli, P., Lasagna, A., Cassaniti, I., Ferrari, A., Bergami, F., Silvestris, N., Sapuppo, E., Di Maio, M., Cinieri, S., Baldanti, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434335/ https://www.ncbi.nlm.nih.gov/pubmed/35853350 http://dx.doi.org/10.1016/j.esmoop.2022.100548

Ejemplares similares

Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM)
por: Pedrazzoli, P., et al.
Publicado: (2023)

Management of patients with end-stage renal disease undergoing chemotherapy: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Nefrologia (SIN)
por: Pedrazzoli, Paolo, et al.
Publicado: (2017)

COVID-19 infection in cancer patients: what has been the contribution of Associazione Italiana Oncologia Medica (AIOM) to oncological care since the beginning of the first pandemic wave?
por: Silvestris, N., et al.
Publicado: (2021)

Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper
por: Silvestris, N., et al.
Publicado: (2021)

Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper
por: Gallo, M., et al.
Publicado: (2021)

8th Congresso dell'Associazione Italiana del Vuoto
por: Associazione Italiana del Vuoto
Publicado: (1983)

8th Congresso dell'Associazione Italiana del Vuoto
por: Associazione Italiana del Vuoto
Publicado: (1983)

Oncología médica
Publicado: (1980)

Whole Lung Irradiation after High-Dose Busulfan/Melphalan in Ewing Sarcoma with Lung Metastases: An Italian Sarcoma Group and Associazione Italiana Ematologia Oncologia Pediatrica Joint Study
por: Abate, Massimo E., et al.
Publicado: (2021)

Clinical nutrition in surgical oncology: Young AIOM-AIRO-SICO multidisciplinary national survey on behalf of NutriOnc research group
por: Marano, Luigi, et al.
Publicado: (2023)

Fundamentos de oncología médica
por: González Barón, Manuel
Publicado: (1989)

Blinatumomab in Children and Adolescents with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: A Real-Life Multicenter Retrospective Study in Seven AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) Centers
por: Beneduce, Giuliana, et al.
Publicado: (2022)

Storia dell’igiene industriale: la Clinica del Lavoro di Milano e l’Associazione Italiana degli Igienisti Industriali
por: Cavallo, Domenico M., et al.
Publicado: (2019)

Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP)
por: Zama, Daniele, et al.
Publicado: (2022)

Fundamentos de oncología médica para enfermeras :conocimiento teórico y práctico
por: Sánchez Gutierrrez, Esther M. M.
Publicado: (2004)

Italian standards for diabetes mellitus 2007: executive summary: Diabete Italia, AMD Associazione Medici Diabetologi, SID Società Italiana di Diabetologia
por: De Micheli, Alberto
Publicado: (2008)

Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up
por: Lasagna, Angioletta, et al.
Publicado: (2023)

Un Relato Historico de la Oncología Médica en México /
por: Garza Salazar, Jaime G. de la
Publicado: (2011)

Effectiveness of the available early therapies in reducing severe COVID-19 in non-hospitalized patients with solid tumors on active treatment
por: Lasagna, Angioletta, et al.
Publicado: (2022)

Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment
por: Lasagna, A., et al.
Publicado: (2022)

Oncología
por: Peterson, B.
Publicado: (1982)

Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern
por: Lasagna, A., et al.
Publicado: (2022)

Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM)
por: Conforti, F., et al.
Publicado: (2021)

Oncología básica /
por: Cuevas Torres, J. J.
Publicado: (1985)

Oncología ginecológica
por: Flores Flores, Guillermo
Publicado: (2011)

Oncología clínica
Publicado: (2001)

Oncología ginecológica
Publicado: (2000)

Oncología práctica /
Publicado: (1995)

Oncología ginecológica
Publicado: (1991)

Oncología clínica
Publicado: (1992)

Oncología clínica
Publicado: (1998)

Oncología clínica
Publicado: (2005)

Oncología clínica /
Publicado: (2005)

Oncología clínica
Publicado: (1997)

Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study
por: Lasagna, A., et al.
Publicado: (2022)

Oncología : manual de interpretación clínica /
por: Gutiérrez Herrera, José Luis
Publicado: (1998)

Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up
por: Lasagna, A., et al.
Publicado: (2021)

Hemato-oncología pediátrica
Publicado: (2006)

Oncología medicoquirúrgica pediátrica
Publicado: (2001)

Oncología ginecológica clínica /
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_i854bt36b7bolnfe3eb1iccnk6